April FDA review date set for silicone breast implants
This article was originally published in Clinica
FDA advisors are set to decide again whether they should recommend that silicone gel breast implants re-enter the US market. The agency's general and plastic surgery advisory panel will on April 11-13 review premarket approval (PMA) applications for implants filed by Inamed and Mentor. The FDA usually follows the advice of its panel.